09:43 AM EST - BioVaxys Technology Corp : Announced today that in an action that further expands the value of their IP portfolio, the Company has broadened the patent coverage for its viral vaccine platform by filing an international patent application through the Patent Cooperation Treaty for BVX-1021, it's vaccine for SARS1 and other sarbecoviruses. BioVaxys Technology Corp
shares C.BIOV are trading unchanged at $0.11.
